Optimisation of atorvastatin dosing for the treatment of familial hypercholesterolemia in paediatric patients

被引:0
|
作者
D'Agate, Salvatore [1 ,2 ]
Velickovic, Peter [1 ,2 ]
Buonuomo, Paola Sabrina [3 ]
Rana, Ippolita [3 ]
Bartuli, Andrea [3 ]
Biondi, Isabella [4 ]
Ciabattini, Marco [4 ]
Pontrelli, Giuseppe [4 ]
Goffredo, Bianca Maria [5 ]
Della Pasqua, Oscar [1 ,2 ]
机构
[1] UCL, Clin Pharmacol & Therapeut Grp, London, England
[2] CNR, Ist Applicaz Calcolo, Rome, Italy
[3] Osped Pediat Bambino Gesu, Rare Dis & Med Genet Unit, Rome, Italy
[4] Osped Pediat Bambino Gesu, Clin Trials Ctr, Rome, Italy
[5] Osped Pediat Bambino Gesu, Metab Pathol Lab, Rome, Italy
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OC114
引用
收藏
页码:217 / 218
页数:2
相关论文
共 50 条
  • [21] Decrease of LDL-apheresis frequency with atorvastatin treatment in severe familial hypercholesterolemia (FH)
    Erlich, D
    Chiali, A
    Warnet, A
    Farges, D
    Goussault, Y
    Bussel, A
    ATHEROSCLEROSIS, 1999, 144 : 204 - 204
  • [22] Augmented resting myocardial perfusion in familial hypercholesterolemia and its normalization after atorvastatin treatment
    Lario, F. C.
    Miname, M. H. M.
    Tsutsui, J. M.
    Kowatsch, I.
    Vieira, M. L. C.
    Santos Filho, R. D.
    Mathias Junior, W.
    EUROPEAN HEART JOURNAL, 2009, 30 : 795 - 795
  • [23] THE IMPACT OF ATORVASTATIN TREATMENT ON DIASTOLIC DYSFUNCTION IN ISOLATED HYPERCHOLESTEROLEMIA PATIENTS
    Sozen, S. B.
    Sumerkan, M. C.
    Yazici, M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 163 : S50 - S51
  • [24] Atorvastatin 20 mg/day in the treatment of patients with hereditary hypercholesterolemia
    Susekov, AV
    Balakhonova, TV
    Pogorelova, OA
    Aligisheeva, ZA
    Titov, VN
    Atkov, OY
    Kukharchuk, VV
    KARDIOLOGIYA, 2003, 43 (08) : 36 - 39
  • [25] Alirocumab dosing patterns during 40 months of open-label treatment in patients with heterozygous familial hypercholesterolemia
    Hovingh, G. Kees
    Guyton, John R.
    Langslet, Gisle
    Dufour, Robert
    Baccara-Dinet, Marie T.
    Din-Bell, Chantal
    Manvelian, Garen
    Farnier, Michel
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (06) : 1463 - 1470
  • [26] Treatment of familial hypercholesterolemia
    Wolfram, G
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (22) : 674 - 674
  • [27] Lipid-lowering effect of atorvastatin in homozygous familial hypercholesterolemia patients with portocaval anastomosis
    Gaudet, D
    Couture, P
    Tremblay, G
    Brun, D
    Perron, P
    Bergeron, J
    Gagne, C
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 124 - 124
  • [28] TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA
    VANITALL.TB
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1967, 202 (10): : 996 - &
  • [29] COMPARATIVE EFFECT OF APHERESIS VS ATORVASTATIN/APHERESIS ON MARKERS OF INFLAMMATION IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    Puntoni, M.
    Sbrana, F.
    Bigazzi, F.
    Minichilli, F.
    Sampietro, T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 26 - 27
  • [30] COMPARATIVE EFFECT OF APHERESIS VS ATORVASTATIN/APHERESIS ON MARKERS OF INFLAMMATION IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    Puntoni, M.
    Bigazzi, F.
    Sbrana, F.
    Pennato, B.
    Minichilli, F.
    Sampietro, T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 120 - 120